Quantbot Technologies LP Invests $1.95 Million in BellRing Brands, Inc. (NYSE:BRBR)

Quantbot Technologies LP bought a new stake in shares of BellRing Brands, Inc. (NYSE:BRBR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 32,063 shares of the company’s stock, valued at approximately $1,947,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Qsemble Capital Management LP purchased a new stake in shares of BellRing Brands during the 3rd quarter worth approximately $1,070,000. Hancock Whitney Corp purchased a new stake in BellRing Brands during the third quarter valued at $603,000. Truvestments Capital LLC purchased a new position in shares of BellRing Brands in the 3rd quarter worth $44,000. Daiwa Securities Group Inc. increased its holdings in shares of BellRing Brands by 125.0% in the 3rd quarter. Daiwa Securities Group Inc. now owns 8,100 shares of the company’s stock worth $492,000 after buying an additional 4,500 shares during the last quarter. Finally, Algert Global LLC raised its position in shares of BellRing Brands by 12.6% during the 3rd quarter. Algert Global LLC now owns 319,690 shares of the company’s stock valued at $19,412,000 after buying an additional 35,774 shares in the last quarter. Institutional investors own 94.97% of the company’s stock.

Wall Street Analysts Forecast Growth

BRBR has been the topic of a number of recent research reports. JPMorgan Chase & Co. decreased their price objective on BellRing Brands from $65.00 to $64.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Truist Financial raised their price target on BellRing Brands from $60.00 to $75.00 and gave the stock a “hold” rating in a research report on Wednesday, November 20th. Stifel Nicolaus increased their target price on shares of BellRing Brands from $67.00 to $81.00 and gave the company a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group upped their price target on shares of BellRing Brands from $61.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Finally, Citigroup raised their price objective on shares of BellRing Brands from $72.00 to $83.00 and gave the stock a “buy” rating in a research note on Wednesday, November 20th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $75.60.

BellRing Brands Trading Down 2.1 %

Shares of BellRing Brands stock opened at $77.16 on Friday. The stock’s fifty day moving average price is $67.10 and its 200-day moving average price is $59.85. The firm has a market cap of $9.97 billion, a P/E ratio of 41.26, a P/E/G ratio of 2.58 and a beta of 0.84. BellRing Brands, Inc. has a 12 month low of $48.06 and a 12 month high of $79.90.

BellRing Brands (NYSE:BRBR) last posted its earnings results on Monday, November 18th. The company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.01. BellRing Brands had a net margin of 12.35% and a negative return on equity of 103.89%. The business had revenue of $555.80 million for the quarter, compared to the consensus estimate of $545.00 million. During the same quarter last year, the firm posted $0.41 EPS. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. Analysts forecast that BellRing Brands, Inc. will post 2.16 earnings per share for the current year.

BellRing Brands Profile

BellRing Brands, Inc, together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club, food, drug, mass, eCommerce, specialty, and convenience channels.